NCT00256542

Study of U101 for Bladder Pain and/or Urgency

A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 90 (planned)
• Sponsor: Urigen · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether intravesical U101 (alkalinized lidocaine-heparin) treatment reduces the symptoms of pelvic pain and/or urgency of bladder origin.

Conditions

• Pelvic Pain
• Interstitial Cystitis
• Bladder Diseases

Interventions

Type	Name	Description
DRUG	Alkalinized Lidocaine-Heparin

Timeline

• Start date: 2006-01-01
• Completion: 2006-09-01
• First posted: 2005-11-21
• Last updated: 2006-09-29

Locations

9 sites across 1 country: United States